C.M. Bidwell & Associates’s Twist Bioscience TWST Stock Holding History

C.M. Bidwell & Associates’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06K	Hold	20	–	–	﹤0.01%	415
2026 Q1	$950	Hold	20	–	–	﹤0.01%	431
2025 Q4	$634	Hold	20	–	–	﹤0.01%	455
2025 Q3	$563	Sell	20 -63	-76%	-$1.91K	﹤0.01%	466
2025 Q2	$3.05K	Hold	83	–	–	﹤0.01%	365
2025 Q1	$3.26K	Hold	83	–	–	﹤0.01%	360
2024 Q4	$3.86K	Hold	83	–	–	﹤0.01%	371
2024 Q3	$3.75K	Hold	83	–	–	﹤0.01%	393
2024 Q2	$4.09K	Hold	83	–	–	﹤0.01%	340
2024 Q1	$2.85K	Hold	83	–	–	﹤0.01%	396
2023 Q4	$3.06K	Hold	83	–	–	﹤0.01%	390
2023 Q3	$1.68K	Hold	83	–	–	﹤0.01%	488
2023 Q2	$1.7K	Hold	83	–	–	﹤0.01%	480
2023 Q1	$1.25K	Hold	83	–	–	﹤0.01%	489
2022 Q4	$1.98K	Buy	83 +63	+315%	+$1.83K	﹤0.01%	454
2022 Q3	$1K	Hold	20	–	–	﹤0.01%	466
2022 Q2	$1K	Hold	20	–	–	﹤0.01%	477
2022 Q1	$1K	Buy	+20	New	+$1.11K	﹤0.01%	514

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

C.M. Bidwell & Associates's TWST Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Twist Bioscience (TWST) position steady in Q2 2026 at 20 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #415.

C.M. Bidwell & Associates first reported a position in TWST in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.09K in Q2 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

C.M. Bidwell & Associates held 20 shares of Twist Bioscience worth $2.06K as of Q2 2026.
C.M. Bidwell & Associates left its Twist Bioscience share count unchanged in Q2 2026.
Twist Bioscience made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #415 holding.
C.M. Bidwell & Associates first reported a position in Twist Bioscience in Q1 2022 and has held it in 18 quarters since.
C.M. Bidwell & Associates's Twist Bioscience position peaked at $4.09K in Q2 2024.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.